| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.02 | 0.7 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |